A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

Clinical trial NCT06637514 · COMPLETED

Trial details

NCT number: NCT06637514
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Phenylketonuria (PKU)

Start date: 2025-07-16
Primary completion: 2026-05-08
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.